PyroGenesis Announces 2023 Fourth Quarter and Year End Results
April 01, 2024 23:57 ET
|
PyroGenesis Canada Inc.
MONTREAL, April 01, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs,...
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 21, 2024 07:00 ET
|
Mineralys Therapeutics, Inc.
– Enrollment in the two pivotal trials of lorundrostat for the treatment of uHTN or rHTN is on track, with topline data expected for Advance-HTN trial in Q4 2024 and Launch-HTN trial in 2H 2025 – –...
Cornish Metals Releases Audited Financial Statements and Management’s Discussion and Analysis for the Period Ended December 31, 2023
March 21, 2024 03:00 ET
|
Cornish Metals Inc.
VANCOUVER, British Columbia, March 21, 2024 (GLOBE NEWSWIRE) -- Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on...
Smart Implants Market Size to Reach USD 22.5 Billion by 2032
March 11, 2024 11:00 ET
|
Precedence Research
Ottawa, March 11, 2024 (GLOBE NEWSWIRE) -- The global smart implants market size is calculated at USD 6.1 billion for 2024 and is projected to surpass around USD 15.8 billion by 2030, a study...
Healthcare Digital Twin Market Size to Worth USD 38.43 Bn by 2032
March 08, 2024 11:25 ET
|
Precedence Research
Ottawa, March 08, 2024 (GLOBE NEWSWIRE) -- The global healthcare digital twin market size accounted for USD 2.24 billion in 2024, grew to USD 3.13 billion in 2025, and is expanding at a remarkable...
HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
February 28, 2024 06:30 ET
|
HUTCHMED (China) Limited
Revenue grew 97% (102% CER) to US$838 million, with net income of US$101 million First U.S. FDA approval of our self-developed medicine, FRUZAQLA™ (fruquintinib) Sovleplenib for ITP accepted for...
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
February 22, 2024 07:30 ET
|
Harmony Biosciences
WAKIX® (pitolisant) Net Revenue of $168.4 Million for Fourth Quarter and $582.0 Million for Full Year 2023; Representing Growth of ~31% and ~33%, Respectively U.S. Food and Drug Administration...
Stroke Diagnostics and Therapeutics Market Size to Hit USD 66.41 Bn by 2032
February 21, 2024 11:00 ET
|
Precedence Research
Ottawa, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The global stroke diagnostics and therapeutics market size accounted for USD 36.87 billion in 2024 and is expanding at a CAGR of 7.2% during the forecast...
SEQUANA MEDICAL ANNOUNCES EUR 3.0 MILLION CONVERTIBLE FINANCING FROM MAJOR SHAREHOLDERS AND AGREEMENT WITH LENDERS ON DEFERRAL OF DEBT SERVICE PAYMENTS
February 08, 2024 01:00 ET
|
Sequana Medical NV
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED...
eDiscovery Market Size to grow by USD 32.5 billion by 2033, Driven by Digitization Trends and Regulatory Compliance Needs
February 07, 2024 06:20 ET
|
Market.Us
New York, Feb. 07, 2024 (GLOBE NEWSWIRE) -- According to Market.us, The eDiscovery Market size was projected to be USD 13.6 billion in 2023, and by the end of 2024, it is expected to reach a...